Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen gel for acute musculoskeletal pain
NCT05013567Phase 3Unknown
- Sponsor
- Brainfarma
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ibuprofen in acute musculoskeletal pain, sponsored by Brainfarma. Status: unknown.
02
Drugs
ibuprofen
03
Conditions
acute musculoskeletal pain
Beyond the preview
Go deeper on NCT05013567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05013567.